Saturday, March 17, 2012 10:14:54 AM
Does anyone think for one second that Whelan and everyone else inside BIEL isn't crawling out of their skin with impatience? I sure would be, I'm twitching thinking about it. And the ALLAY application covers menstrual pain and cramps for women who will no longer have to take drugs every month? Huge market!
I like where we are and the fact that the guy who stands to win the most is the largest shareholder in the company. If I'm CEO of J&J I'm watching this like a hawk. When BIEL gets approval, it's an instant target! And if J&J gets it, J&J just bought an edge on all its drug competitors. Nice place to be.
I know I'm being repetitive, but it just makes no sense to me that a surgeon can prescribe the already approved RecoveryRx for me after he operates on my eye, to promote better, faster recovery/healing and I can wear a RecoveryRX next to my brain and the FDA won't approve ALLAY for women and ActiPatch for aches, pain, sprains, etc. I'm staying right where I am, patiently waiting for approval. Happy St. Pati's Day
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM